75%Confidence
0Views
FDASource
2026-04-09Date
Summary
Annora Pharma's Class III recall for Pitavastatin tablets due to incorrect tablet mixing poses a low health risk but reveals serious packaging errors at an Indian manufacturer supplying Northstar Rx. This highlights quality control vulnerabilities in generic drug manufacturing, potentially leading to stricter FDA oversight of foreign production sites.
Actionable: Review the quality audit history of Annora Pharma to gauge systemic risks in their manufacturing processes.
AI Confidence: 75%
Data Points
firmAnnora Pharma Private Limited
classificationClass III
statusOngoing
distributionTN
productPitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Phar
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now